Fatty Acids in the Meat of Buffaloes Supplemented with Fish Oil

The purpose of this study has been to investigate the influence of both a supplementary fish oil diet on conjugated linoleic acid (CLA) and n6 and n3 fatty acids on intramuscular fat in Mediterranean buffalo meat. Twenty animals were randomly divided into two groups and fed with Brachiaria brizantha, 3Kg rice bran, 500 g corn and 500 g sunflower pellets for 60 days. Group I received this diet only while in group II each animal received additional 100 ml fish oil daily. Results indicated a significant decrease of palmitic fatty acid in group II (232.67 mg/g fat) in relation to group I (254.73 mg/g fat). Among unsaturated acids (AGI), the 9c 11t CLA value of group II (21.23 mg/g fat) showed an increase in relation to group I (15.80 mg/g fat), while the linoleic acid content of group II (28,85 mg/g fat) decreased significantly in relation to group I (47,00 mg/g fat). However, the alpha linolenic acid showed no significant difference between the supplemented diet group and the control group (10.31 and 10.70 mg/g fat, respectively). Group II n6/n3 ratio was narrower (2.69:1) than that of group I (4.55:1). Summing up, group II diet, which included fish oil, increased the CLA content in intramuscular fat and decreased the n6 fatty acids, improving the n6/n3 ratio

Influence of fish oil in the concentration of conjugated linoleic acid and omega 6 and 3 in buffalo milk

The aim of this research work was to investigate the influence of fish oil supplementation on the concentration of conjugated linoleic acid (CLA) and omega 6 and 3 in samples of buffalo milk. A total of 24 female buffaloes separated at random into three groups were fed for 49 days with: natural pasture (group I), supplemented with 70mL of fish oil (group II) and 140mL of fish oil (group III). In the experiment the concentration of CLA showed differences (P<0.05) among the three groups, with a maximum of 7.14mg/g fat in group II. No significant differences were found in omega-6 among the three groups. The highest value of 3.82mg/g fat corresponded to group I, whicht had not been supplemented with fish oil. Significant differences were observed in omega 3 (P<0.05) in groups II and III with respect to group I. The highest average value of 2.42mg/g fat was obtained in group III. The closest relationship omega 6/3 (1.37:1) was observed in group III. As a result, the diets of groups II and III, which included fish oil, increased significantly the content of CLA and omega 3 with reductions in levels of omega 6

International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis.

A clear dosing regimen for methotrexate in psoriasis is lacking, and this might lead to a suboptimal treatment. Because methotrexate is affordable and globally available, a uniform dosing regimen could potentially optimize the treatment of patients with psoriasis worldwide. To reach international consensus among psoriasis experts on a uniform dosing regimen for treatment with methotrexate in adult and pediatric patients with psoriasis and identify potential future research topics. Between September 2020 and March 2021, a survey study with a modified eDelphi procedure that was developed and distributed by the Amsterdam University Medical Center and completed by 180 participants worldwide (55 [30.6%] resided in non-Western countries) was conducted in 3 rounds. The proposals on which no consensus was reached were discussed in a conference meeting (June 2021). Participants voted on 21 proposals with a 9-point scale (1-3 disagree, 4-6 neither agree nor disagree, 7-9 agree) and were recruited through the Skin Inflammation and Psoriasis International Network and European Academy of Dermatology and Venereology in June 2020. Apart from being a dermatologist/dermatology resident, there were no specific criteria for participation in the survey. The participants worked mainly at a university hospital (97 [53.9%]) and were experienced in treating patients with psoriasis with methotrexate (163 [91.6%] had more than 10 years of experience). In a survey with eDelphi procedure, we tried to reach consensus on 21 proposals. Consensus was defined as less than 15% voting disagree (1-3). For the consensus meeting, consensus was defined as less than 30% voting disagree. Of 251 participants, 180 (71.7%) completed all 3 survey rounds, and 58 participants (23.1%) joined the conference meeting. Consensus was achieved on 11 proposals in round 1, 3 proposals in round 2, and 2 proposals in round 3. In the consensus meeting, consensus was achieved on 4 proposals. More research is needed, especially for the proposals on folic acid and the dosing of methotrexate for treating subpopulations such as children and vulnerable patients. In this eDelphi consensus study, consensus was reached on 20 of 21 proposals involving methotrexate dosing in patients with psoriasis. This consensus may potentially be used to harmonize the treatment with methotrexate in patients with psoriasis